Jennifer Cunningham, a nurse, saw that her husband's eye looked smaller. Eventually, he decided to see a doctor. He had a ...

By studying mutations in malignant T cells that cause lymphoma, they zeroed in on one that imparted exceptional potency to ...

The U.S. health regulator on Wednesday approved the expanded use of Bristol Myers Squibb's cancer cell therapy Breyanzi for ...

Bristol Myers Squibb’s CAR T Cell Therapy Breyanzi Approved by the U.S. Food and Drug Administration for Relapsed or ...

Researchers from the Cancer Science Institute of Singapore (CSI) at the National University of Singapore (NUS), have achieved ...

Being vegan or vegetarian dramatically reduces the risk of cancer, heart disease and early death, a new study found.

Jeff Bridges provides a health update three years post-lymphoma diagnosis, expressing his journey as dancing with mortality.

Isabel elaborated on her experience in a lengthy caption, admitting her initial disregard for an early cancer symptom — a ...

AstraZeneca’s blockbuster BTK inhibitor Calquence significantly improved progression-free survival when used as a frontline ...

Kyowa Kirin, Inc. a wholly owned subsidiary of Kyowa Kirin Co. Ltd, today announced the publication of a patient-focused global consensus statement – 'Time to Act: A Global Patient-Focused Consensus ...

Kite, a Gilead Company (Nasdaq: GILD), today announced 12 abstracts from its industry-leading Chimeric Antigen Receptor (CAR) T-cell therapy portfolio at the upcoming 2024 European Hematology ...